high risk populations

Embed Size (px)

DESCRIPTION

nursing schooooool.

Citation preview

  • 7/18/2019 high risk populations

    1/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Chapter 20Nursing Management of the Pregnancy at

    Risk: Selected Health Conditions andVulnerale Populations

    Maternity and Pediatric Nursing

  • 7/18/2019 high risk populations

    2/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    KEY TERMS

    acquired immunodeficiency syndrome (AIDS)

    Adolescence

    anemia

    fetal alcohol spectrum disorder (FASD)

    gestational diabetes mellitus

    glycosylated hemoglobin(HbA1C) leel

    human immunodefciency irus (HI!)

    impaired fasting glucose

    impaired glucose tolerance

  • 7/18/2019 high risk populations

    3/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    KEY TERMS

    neonatal astinence syn!rome

    perinatal !rug ause

    "ica

    "re#gestational !iaetes

    teratogen

    type $ !iaetes

    type 2 !iaetes

  • 7/18/2019 high risk populations

    4/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Diabetes Mellitus

    ! "ypical classification

    # "ype $

    # "ype 2

    # %mpaired fasting glucose and impaired glucosetolerance

    # &estational diaetes! Classification during pregnancy

    # Pregestational diaetes

    # &estational

  • 7/18/2019 high risk populations

    5/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Diabetes Mellitus (contd)

    ! Pathophysiology and pregnancy

    # 'etal demands# Role of placental hormones

    # Changes in insulin resistance

    # (ffects on mother

    # (ffects on fetus )see "ale 20*$+

  • 7/18/2019 high risk populations

    6/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Diabetes Mellitus (contd)

    ! "herapeutic management

    # Preconception counseling# ,lood glucose le-el control )H.$C /1+

    # &lycemic control

    # Nutritional management# Hypoglycemic agents

    # Close maternal and fetal sur-eillance

    # Management during laor and irth

  • 7/18/2019 high risk populations

    7/31Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Diabetes Mellitus (contd)

    ! .ssessment

    # Health history physical e3amination risk factors

    # Screening at first prenatal -isit additional

    screening at 24 to 25 6eeks for 6omenconsidered at risk

    # Maternal sur-eillance: urine for protein7 ketones7nitrates7 and leukocyte esterase e-aluation of

    renal function8trimester eye e3am in $st

    trimester H.$c 9 4* 6eeks

    # 'etal sur-eillance: ultrasound alpha*fetoproteinle-els iophysical profile nonstress testingamniocentesis

  • 7/18/2019 high risk populations

    8/31Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Diabetes Mellitus (contd)

    ! Nursing management )see Nursing Care Plan 20*$+

    # ;ptimal glucose control! ,lood glucose le-els medication therapy

    ! Nutritional therapy

    ! Measures during laor and irth postpartum

    # Pre-ention of complications

    # Client education and counseling )see "eaching

    &uidelines 20*$+

  • 7/18/2019 high risk populations

    9/31Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Question

    %s the follo6ing statement "rue or 'alsecra-ings=

    ! ,= "here is progressi-e resistance to the effects of

    insulin=

    ! C= Hypoinsulinemia de-elops early in the Krst trimester=

    ! A= &lucose le-els decrease to accommodate fetal gro6th=

  • 7/18/2019 high risk populations

    26/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Re,ie

    ! "he correct response is ,:

    ! caused le-els of the hormone hP )insulin antagonist+progressi-ely rise throughout pregnancy7 and additional insulinis needed to o-ercome its resistance= Ha-ing a carohydratecra-ing is not associated 6ith gestational diaetes=Hyperinsulinemia in the fetus de-elops in response to themother>s high lood glucose le-els= &lucose le-els are di-ertedacross the placenta for fetal use7 and thus maternal le-els arereduced in the first trimester= "his lo6er glucose le-el doesn>tlast throughout the gestation7 Just the first trimester= 'or theremaining t6o trimesters7 the maternal glucose le-els are highecause of the insulin resistance y hP=

  • 7/18/2019 high risk populations

    27/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Re,ie

    ! Ghen pro-iding prenatal education to a pregnant6oman 6ithasthma7 6hich of the follo6ing 6ould eimportant for thenurse to dos glucosele-els7 unless she also has diaetes= ,ronchodilators usuallyare inhaled7 not gi-en sucutaneously7 so instruction aout thisroute of administration 6ould not e necessary=

  • 7/18/2019 high risk populations

    29/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Re,ie

    ! Ghich of the follo6ing conditions 6ould most likely causea pregnant 6oman 6ith type $ diaetes the greatest

    difKculty during her pregnancy

    ! = Hyperemesis gra-idarum

    ! c= .ruptio placentae

    ! d= Rh incompatiility

  • 7/18/2019 high risk populations

    30/31

    Copyright 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

    Re,ie

    ! "he correct response is ,:

    ! "he highest percentage of H%V transmission results fromse3ual acti-ity7 follo6ed y intra-enous drug use="ransmission can occur despite a lo6 -iral load in thelood of the infected person= Pregnant 6omen 6ho takeantiretro-iral therapy during their gestation significantlyreduce the chances of transmitting H%V to their ne6orn=

    "he use of standard precautions 6ill minimi?e the risk oftransmission of H%V to health care 6orkers= . -ery smallpercentage of nurses contract H%V through needlesticks ifusing appropriate precautions=

  • 7/18/2019 high risk populations

    31/31

    T$e End// Questions00